Publicaciones en las que colabora con Jesús Barrio Andrés (9)

2023

  1. Helicobacter pylori Diagnostic Tests Used in Europe: Results of over 34,000 Patients from the European Registry on Helicobacter pylori Management

    Journal of Clinical Medicine, Vol. 12, Núm. 13

  2. Influence of HLADQA1*05 Genotype in Adults With Inflammatory Bowel Disease and Anti-TNF Treatment With Proactive Therapeutic Drug Monitoring: A Retrospective Cohort Study

    Inflammatory bowel diseases, Vol. 29, Núm. 10, pp. 1586-1593

2022

  1. Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study (J. Clin. Med., (2021), 10, (2885), 10.3390/jcm10132885)

    Journal of Clinical Medicine

2021

  1. The role of statins on helicobacter pylori eradication: Results from the european registry on the management of h. pylori (hp-eureg)

    Antibiotics, Vol. 10, Núm. 8

2019

  1. Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial

    Therapeutic Advances in Gastroenterology, Vol. 12

2017

  1. Clinical status, quality of life, and work productivity in Crohn’s disease patients after one year of treatment with adalimumab

    Revista Española de Enfermedades Digestivas, Vol. 109, Núm. 2, pp. 122-129

2016

  1. The utility of faecal calprotectin to predict post-operative recurrence in Crohn's disease

    Scandinavian Journal of Gastroenterology, Vol. 51, Núm. 6, pp. 720-726

2015

  1. Frecuencia, factores predictores y consecuencias de la intensificación del tratamiento de mantenimiento con infliximab en la colitis ulcerosa

    Revista Española de Enfermedades Digestivas, Vol. 107, Núm. 9, pp. 527-533

2013

  1. Crohn's disease diagnosis during adalimumab treatment

    Scandinavian Journal of Gastroenterology, Vol. 48, Núm. 2, pp. 254-255